Barchart.com
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Menu
alerts false
Stocks | Futures | Watchlist | News | More
 
Advanced search
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Menu

Nuvectis Pharma Inc (NVCT)

Nuvectis Pharma Inc (NVCT)
7.68 x 5 9.80 x 13
Pre-market by (Cboe BZX)
8.24 -0.01 (-0.12%) 04/07/25 [NASDAQ]
7.68 x 5 9.80 x 13
Pre-market 7.50 -0.74 (-8.98%) 04:49 ET
News & Headlines for Mon, Apr 7th, 2025
Notes
Alerts
Watch
    Add or delete the symbol from one or more Watchlists.
  • Create New Watchlist
    This name already in use.
Help
Go To:
Nuvectis Pharma Announces Upcoming Presentations for NXP900 at the 2025 American Association for Cancer Research Meeting GlobeNewswire - Wed Mar 26, 7:00AM CDT

NVCT : 8.24 (-0.12%)
Nuvectis Pharma to Participate in the 37th Annual Roth Conference GlobeNewswire - Fri Mar 14, 7:00AM CDT

NVCT : 8.24 (-0.12%)
Nuvectis Pharma Announces a New Publication of a Research Study Demonstrating that the Combination of NXP900 and EGFR Inhibitors Improves the Efficacy of the EGFR Inhibitors in Preclinical Models of EGFR Mutated NSCLC GlobeNewswire - Tue Mar 4, 7:00AM CST

NVCT : 8.24 (-0.12%)
Nuvectis Pharma, Inc. Reports 2024 Financial Results and Business Highlights GlobeNewswire - Tue Feb 25, 7:00AM CST

NVCT : 8.24 (-0.12%)
Nuvectis Pharma Announces Closing of $15.5 Million Public Offering of Common Stock and Full Exercise of Underwriter’s Over-Allotment Option GlobeNewswire - Fri Feb 7, 7:30AM CST

NVCT : 8.24 (-0.12%)
Nuvectis Pharma Announces Pricing of $13.5 Million Public Offering of Common Stock GlobeNewswire - Wed Feb 5, 8:01AM CST

NVCT : 8.24 (-0.12%)
Nuvectis Pharma Announces Proposed Public Offering of Common Stock GlobeNewswire - Tue Feb 4, 3:05PM CST

NVCT : 8.24 (-0.12%)
Early-Onset Cancer Trends Spark Interest in Promising Oncology Pipelines BayStreet.ca - Wed Dec 18, 2024

Issued on behalf of Oncolytics Biotech Inc. VANCOUVER – USA News Group News Commentary – The American Cancer Society has unveiled its Advances in Oncology – 2024 Research Highlights report,...

ONCY : 0.5276 (+6.54%)
PSNL : 3.25 (+4.50%)
ALXO : 0.5353 (+3.76%)
ONC.TO : 0.79 (+12.86%)
NVCT : 8.24 (-0.12%)
TEM : 42.70 (+0.28%)
Insider Purchase: 10% owner at $NVCT (NVCT) Buys 17,000 Shares Quiver Quantitative, Inc. - Mon Dec 16, 2024

Marlio Charles Mosseri, a 10% owner of $NVCT ($NVCT), bought 17,000 shares of the company on 12-13-2024. This trade was reported by Quiver Quantitative using data from a recent SEC filing. This increased...

NVCT : 8.24 (-0.12%)
Nuvectis Pharma to Present at the 2024 Ladenburg Virtual Oncology Innovators & Investors Symposium GlobeNewswire - Tue Dec 10, 2024

NVCT : 8.24 (-0.12%)

Barchart Exclusives

Frozen Potatoes, Big Macs, and Toothpaste: 3 Consumer Staples Stocks to Load Up on as Trade War Panic Escalates Barchart - 25 minutes ago
These consumer staples stocks could benefit significantly as investors pile into defensive companies. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Trader's Cheat Sheet: Your Secret Weapon for Smarter Trades
Wed, Apr 09, 2025 5:00 PM UTC
Reserve Your Spot